Signal Transduction and Targeted Therapy
Q1 Journal
Open Access
Journal
Country
United Kingdom
Western Europe
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Cancer Research
Q1
└
Genetics
Q1
Publisher
SJR 2025
17.740
Q1
SJR Score
H-Index
224
Citations / Doc (2yr)
51.26
Total Docs. (latest)
423
Total Citations (3yr)
58,350
Publication type
Journals
ISSN
20593635, 20959907
Coverage
2016-2026
Journal Rank
#25
Subject Categories
Cancer Research
Q1
Genetics
Q1
Subject Areas
Aims & Scope
Signal Transduction and Targeted Therapy is an international, peer-reviewed, open-access journal that publishes original research articles and review articles related to all aspects of signal transduction in physiological and pathological processes, as well as signal transduction-targeted therapeutics in the form of biological agents and small molecular drugs used to treat human diseases such as cancer, autoimmune disorders, and others.
This journal focuses on cutting-edge advances both experimentally and clinically.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Medline
PubMed
Embase
Detailed Metrics
| Total Docs. (latest) | 423 |
| Total Docs. (3 years) | 1,207 |
| Total Refs. | 57,802 |
| Total Citations (3 years) | 58,350 |
| Citable Docs. (3 years) | 843 |
| Citations / Doc. (2 years) | 51.26 |
| Ref. / Doc. | 136.65 |
| % Female | 41.3% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.